Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease. - Nevola R; Alfano M; Pafundi PC; Brin C; Gragnano F; Calabrò P; Adinolfi LE; Rinaldi L; Sasso FC; Caturano A (Reviews in cardiovascular medicine, 2022)